# Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

> **NCT00009945** · PHASE3 · COMPLETED · sponsor: **NSABP Foundation Inc** · enrollment: 3323 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** clodronate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00009945
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2011-03
- **Final completion:** 2012-12
- **Target enrollment:** 3323 (ACTUAL)
- **Last updated:** 2017-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00009945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00009945, "Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00009945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*